Covaxin | Bharat Biotech
Bharat Biotech cuts down Covaxin's price for states
Hyderabad/IBNS: Bharat Biotech has reduced the price of Covaxin from Rs 600 per dose to Rs 400 for the state governments in view of the challenges faced by the already overstretched health system, the company said on Thursday.
"Bharat Biotech is deeply concerned with the critical pandemic circumstances that India is facing at this time. Recognising the enormous challenges to the public health care system, we have made Covaxin available to state governments at a price of Rs 400 per dose," the company run by Krishna M Ella said in a statement today.
Bharat Biotech - COVAXIN® Announcement - April 29, 2021 pic.twitter.com/RgnROIfUCe
— BharatBiotech (@BharatBiotech) April 29, 2021
Bharat Biotech said its vaccine will be available for Rs 1200 per dose for private hospitals.
"We wish to be transparent in our approach to pricing which was determined by internally funded project development... and clinical trials," Bharat Biotech said.
Adar Poonawalla's Serum Institute of India has already slashed the price of its Covishield from Rs 400 to Rs 300.
State governments can continue to buy 50 per cent of Covishield and Covaxin to vaccinate the eligible population below 45 years while the Centre will continue to buy the vaccines to inoculate the older population.
Serum Institute has said it will continue to sell Covishield to the Centre at Rs 150.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
